UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION

Washington, D.C. 20549

OMB APPROVAL
  OMB Number:  3235-0582
  Expires:  July 31, 2024
  Estimated average burden
  hours per response........4

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number  811-06565

 

Tekla Healthcare Opportunites Fund

(Exact name of registrant as specified in charter)

 

100 Federal Street, 19th Floor, Boston, MA   02110
(Address of principal executive offices)   (Zip code)

 

Laura Woodward

Tekla Healthcare Opportunities Fund

100 Federal Street, 19th Floor, Boston MA 02110

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:  617-772-8500

 

Date of fiscal year end:  September 30

 

Date of reporting period:  7/1/22-6/30/23

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 

 

 

Item 1. Proxy Voting Record.

 

 

 

  

Vote Summary

 

1LIFE HEALTHCARE, INC.

 

Security 68269G107 Meeting Type Special
Ticker Symbol ONEM Meeting Date 22-Sep-2022
Record Date 22-Aug-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   To adopt the Agreement and Plan of Merger, dated July 20, 2022 (such agreement, as it may be amended, modified or supplemented from time to time, the "Merger Agreement"), by and among 1Life Healthcare, Inc. ("1Life"), a Delaware corporation, Amazon.com, Inc. ("Amazon"), a Delaware corporation, and Negroni Merger Sub, Inc. ("Merger Sub"), a Delaware corporation. Upon the terms and subject to the conditions of the Merger Agreement, Amazon will acquire 1Life via a merger of Merger Sub with and into 1Life, with 1Life continuing as the surviving corporation.   Management   For   For  
2.   To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to 1Life's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.   Management   For   For  
3.   To adjourn the special meeting of the 1Life stockholders (the "Special Meeting") to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting.   Management   For   For  

 

 

 

 

ABBOTT LABORATORIES

 

Security 002824100 Meeting Type Annual
Ticker Symbol ABT Meeting Date 28-Apr-2023
Record Date 01-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: R. J. Alpern   Management   For   For  
1b.   Election of Director: C. Babineaux-Fontenot   Management   For   For  
1c.   Election of Director: S. E. Blount   Management   For   For  
1d.   Election of Director: R. B. Ford   Management   For   For  
1e.   Election of Director: P. Gonzalez   Management   For   For  
1f.   Election of Director: M. A. Kumbier   Management   For   For  
1g.   Election of Director: D. W. McDew   Management   For   For  
1h.   Election of Director: N. McKinstry   Management   For   For  
1i.   Election of Director: M. G. O'Grady   Management   For   For  
1j.   Election of Director: M. F. Roman   Management   For   For  
1k.   Election of Director: D. J. Starks   Management   For   For  
1l.   Election of Director: J. G. Stratton   Management   For   For  
2.   Ratification of Ernst & Young LLP As Auditors   Management   For   For  
3.   Say on Pay - An Advisory Vote on the Approval of Executive Compensation   Management   For   For  
4.   Say When on Pay - An Advisory Vote on the Approval of the Frequency of Shareholder Votes on Executive Compensation   Management   1 Year   For  
5.   Shareholder Proposal - Special Shareholder Meeting Threshold   Shareholder   Against   For  
6.   Shareholder Proposal - Independent Board Chairman   Shareholder   Against   For  
7.   Shareholder Proposal - Lobbying Disclosure   Shareholder   Against   For  
8.   Shareholder Proposal - Incentive Compensation   Shareholder   Against   For  

 

ABBVIE INC.

 

Security 00287Y109 Meeting Type Annual
Ticker Symbol ABBV Meeting Date 05-May-2023
Record Date 06-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Class II Director: Robert J. Alpern   Management   For   For  
1b.   Election of Class II Director: Melody B. Meyer   Management   For   For  
1c.   Election of Class II Director: Frederick H. Waddell   Management   For   For  
2.   Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2023.   Management   For   For  
3.   Say on Pay - An advisory vote on the approval of executive compensation.   Management   For   For  
4.   Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting.   Management   For   For  
5.   Stockholder Proposal - to Implement Simple Majority Vote.   Shareholder   Against   For  
6.   Stockholder Proposal - to Issue an Annual Report on Political Spending.   Shareholder   Against   For  
7.   Stockholder Proposal - to Issue an Annual Report on Lobbying.   Shareholder   Against   For  
8.   Stockholder Proposal - to Issue a Report on Patent Process.   Shareholder   Against   For  

 

 

 

 

ACADIA HEALTHCARE COMPANY, INC.

 

Security 00404A109 Meeting Type Annual
Ticker Symbol ACHC Meeting Date 18-May-2023
Record Date 23-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Michael J. Fucci   Management   For   For  
1b.   Election of Director: Wade D. Miquelon   Management   For   For  
2.   Approve an amendment and restatement of the Acadia Healthcare Company, Inc. Incentive Compensation Plan as presented in the Proxy Statement.   Management   For   For  
3.   Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement.   Management   For   For  
4.   Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  

 

AGILENT TECHNOLOGIES, INC.

 

Security 00846U101 Meeting Type Annual
Ticker Symbol A Meeting Date 15-Mar-2023
Record Date 24-Jan-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director for a three-year term: Heidi K. Kunz   Management   For   For  
1.2   Election of Director for a three-year term: Susan H. Rataj   Management   For   For  
1.3   Election of Director for a three-year term: George A. Scangos, Ph.D.   Management   For   For  
1.4   Election of Director for a three-year term: Dow R. Wilson   Management   For   For  
2.   To approve, on a non-binding advisory basis, the compensation of our named executive officers.   Management   For   For  
3.   To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.   Management   For   For  
4.   To approve amendments to the Certificate of Incorporation to create a new stockholder right to call a special meeting.   Management   For   For  
5.   An advisory vote on the frequency of the stockholder vote to approve the compensation of our named executive officers.   Management   1 Year   For  

 

 

 

 

ALIGN TECHNOLOGY, INC.

 

Security 016255101 Meeting Type Annual
Ticker Symbol ALGN Meeting Date 17-May-2023
Record Date 23-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Kevin J. Dallas   Management   For   For  
1.2   Election of Director: Joseph M. Hogan   Management   For   For  
1.3   Election of Director: Joseph Lacob   Management   For   For  
1.4   Election of Director: C. Raymond Larkin, Jr.   Management   For   For  
1.5   Election of Director: George J. Morrow   Management   For   For  
1.6   Election of Director: Anne M. Myong   Management   For   For  
1.7   Election of Director: Andrea L. Saia   Management   For   For  
1.8   Election of Director: Susan E. Siegel   Management   For   For  
2.   AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION: Proposal to approve the amendment to our Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation.   Management   For   For  
3.   ADVISORY VOTE ON NAMED EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers.   Management   For   For  
4.   ADVISORY VOTE ON FREQUENCY OF STOCKHOLDERS' APPROVAL OF EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Frequency of Stockholders Advisory Vote on Named Executive Officers' Compensation.   Management   1 Year   For  
5.   AMENDMENT TO INCENTIVE PLAN: Approve the Amendment to our 2005 Incentive Plan.   Management   For   For  
6.   RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2023.   Management   For   For  

 

 

 

 

AMEDISYS, INC.

 

Security 023436108 Meeting Type Annual
Ticker Symbol AMED Meeting Date 08-Jun-2023
Record Date 11-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1 Richard M. Ashworth       For   For  
    2 Vickie L. Capps       For   For  
    3 Molly J. Coye, MD       For   For  
    4 Julie D. Klapstein       For   For  
    5 Teresa L. Kline       For   For  
    6 Paul B. Kusserow       For   For  
    7 Bruce D. Perkins       For   For  
    8 Jeffery A. Rideout, MD       For   For  
    9 Ivanetta Davis Samuels       For   For  
2.   To ratify the appointment of KPMG LLP as the Company's independent registered public accountants for the fiscal year ending December 31, 2023.   Management   For   For  
3.   To approve, on an advisory (non-binding) basis, the compensation paid to the Company's Named Executive Officers, as set forth in the Company's 2023 Proxy Statement ("Say on Pay" Vote).   Management   For   For  
4.   To approve, on an advisory (non-binding) basis, the frequency of future stockholder Say on Pay Votes.   Management   1 Year   For  

 

AMERISOURCEBERGEN CORPORATION

 

Security 03073E105 Meeting Type Annual
Ticker Symbol ABC Meeting Date 09-Mar-2023
Record Date 09-Jan-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Ornella Barra   Management   For   For  
1b.   Election of Director: Steven H. Collis   Management   For   For  
1c.   Election of Director: D. Mark Durcan   Management   For   For  
1d.   Election of Director: Richard W. Gochnauer   Management   For   For  
1e.   Election of Director: Lon R. Greenberg   Management   For   For  
1f.   Election of Director: Kathleen W. Hyle   Management   For   For  
1g.   Election of Director: Lorence H. Kim, M.D.   Management   For   For  
1h.   Election of Director: Henry W. McGee   Management   For   For  
1i.   Election of Director: Redonda G. Miller, M.D.   Management   For   For  
1j.   Election of Director: Dennis M. Nally   Management   For   For  
2.   Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2023.   Management   For   For  
3.   Advisory vote to approve the compensation of the Company's named executive officers.   Management   For   For  
4.   Advisory vote on the frequency of a shareholder vote on the compensation of the Company's named executive officers.   Management   1 Year   For  
5.   Shareholder proposal regarding shareholder ratification of termination pay.   Shareholder   Against   For  

 

 

 

 

AMGEN INC.

 

Security 031162100 Meeting Type Annual
Ticker Symbol AMGN Meeting Date 19-May-2023
Record Date 20-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Wanda M. Austin   Management   For   For  
1b.   Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Robert A. Bradway   Management   For   For  
1c.   Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Michael V. Drake   Management   For   For  
1d.   Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Brian J. Druker   Management   For   For  
1e.   Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Robert A. Eckert   Management   For   For  
1f.   Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Greg C. Garland   Management   For   For  
1g.   Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Charles M. Holley, Jr.   Management   For   For  
1h.   Election of Director for a term of office expiring at the 2024 annual meeting: Dr. S. Omar Ishrak   Management   For   For  
1i.   Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Tyler Jacks   Management   For   For  
1j.   Election of Director for a term of office expiring at the 2024 annual meeting: Ms. Ellen J. Kullman   Management   For   For  
1k.   Election of Director for a term of office expiring at the 2024 annual meeting: Ms. Amy E. Miles   Management   For   For  
1l.   Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Ronald D. Sugar   Management   For   For  
1m.   Election of Director for a term of office expiring at the 2024 annual meeting: Dr. R. Sanders Williams   Management   For   For  
2.   Advisory vote on the frequency of future stockholder advisory votes to approve executive compensation.   Management   1 Year   For  
3.   Advisory vote to approve our executive compensation.   Management   For   For  
4.   To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2023.   Management   For   For  

 

ARGENX SE

 

Security 04016X101 Meeting Type Special
Ticker Symbol ARGX Meeting Date 12-Dec-2022
Record Date 08-Nov-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
2.   Appointment of Ana Cespedes as non-executive director to the board of directors of the Company   Management   Abstain      

 

 

 

 

ARGENX SE

 

Security 04016X101 Meeting Type Annual
Ticker Symbol ARGX Meeting Date 02-May-2023
Record Date 04-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
3.   Advisory vote to approve the 2022 remuneration report.   Management   For      
4b.   Adoption of the 2022 annual accounts.   Management   For      
4d.   Allocation of losses of the Company in the financial year 2021 to the retained earnings of the Company.   Management   For      
4e.   Proposal to release the members of the board of directors from liability for their respective duties carried out in the financial year 2022.   Management   For      
5.   Proposal to re-appoint Don deBethizy as non-executive director for a term of two years.   Management   For      
6.   Authorization of the board of directors to issue shares and grant rights to subscribe for shares in the share capital of the Company up to a maximum of 10% of the outstanding capital at the date of the general meeting, for a period of 18 months from the annual general meeting and to limit or exclude statutory pre-emptive rights, if any.   Management   For      
7.   Appointment of Deloitte Accountants B.V. as statutory auditor for the 2023 financial year.   Management   For      

 

ARISTEA THERAPEUTICS, INC.

 

Security N/A Meeting Type Written Consent
Ticker Symbol N/A Meeting Date 7-Jul-2022
Record Date N/A    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Appoint Independent director   Management   For   For  

 

ARISTEA THERAPEUTICS, INC.

 

Security N/A Meeting Type Written Consent
Ticker Symbol N/A Meeting Date 7-Jul-2022
Record Date N/A    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Appoint Series A director   Management   For   For  

 

 

 

 

ASSERTIO HOLDINGS, INC.

 

Security 04546C205 Meeting Type Annual
Ticker Symbol ASRT Meeting Date 10-May-2023
Record Date 31-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director to serve until the 2024 Annual Meeting of Stockholders: Heather L. Mason   Management   For   For  
1.2   Election of Director to serve until the 2024 Annual Meeting of Stockholders: William T. McKee   Management   For   For  
1.3   Election of Director to serve until the 2024 Annual Meeting of Stockholders: Daniel A. Peisert   Management   For   For  
1.4   Election of Director to serve until the 2024 Annual Meeting of Stockholders: Peter D. Staple   Management   For   For  
1.5   Election of Director to serve until the 2024 Annual Meeting of Stockholders: James L. Tyree   Management   For   For  
2.   To approve an amendment and restatement of the Company's Amended and Restated 2014 Omnibus Incentive Plan to increase the number of shares available for issuance thereunder.   Management   For   For  
3.   To approve, on an advisory basis, the compensation of the Company's named executive officers.   Management   For   For  
4.   To conduct, on an advisory basis, a vote on the preferred frequency of future advisory votes to approve the compensation of the Company's named executive officers.   Management   1 Year   For  
5.   To approve an amendment to the Amended and Restated Certificate of Incorporation of Assertio Therapeutics, Inc., a wholly-owned subsidiary of the Company, to eliminate the pass-through voting provision.   Management   For   For  
6.   To ratify the appointment of Grant Thornton LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  

 

 

 

 

ASTRAZENECA PLC

 

Security 046353108 Meeting Type Annual
Ticker Symbol AZN Meeting Date 27-Apr-2023
Record Date 10-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022   Management   For   For  
2.   To confirm dividends   Management   For   For  
3.   To reappoint PricewaterhouseCoopers LLP as Auditor   Management   For   For  
4.   To authorise the Directors to agree the remuneration of the Auditor   Management   For   For  
5a.   Re-election of Director: Michel Demaré   Management   For   For  
5b.   Re-election of Director: Pascal Soriot   Management   For   For  
5c.   Re-election of Director: Aradhana Sarin   Management   For   For  
5d.   Re-election of Director: Philip Broadley   Management   For   For  
5e.   Re-election of Director: Euan Ashley   Management   For   For  
5f.   Re-election of Director: Deborah DiSanzo   Management   For   For  
5g.   Re-election of Director: Diana Layfield   Management   For   For  
5h.   Re-election of Director: Sheri McCoy   Management   For   For  
5i.   Re-election of Director: Tony Mok   Management   For   For  
5j.   Re-election of Director: Nazneen Rahman   Management   For   For  
5k.   Re-election of Director: Andreas Rummelt   Management   For   For  
5l.   Re-election of Director: Marcus Wallenberg   Management   For   For  
6.   To approve the Annual Report on Remuneration for the year ended 31 December 2022   Management   For   For  
7.   To authorise limited political donations   Management   For   For  
8.   To authorise the Directors to allot shares   Management   For   For  
9.   To authorise the Directors to disapply pre-emption rights (Special Resolution)   Management   For   For  
10.   To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution)   Management   For   For  
11.   To authorise the Company to purchase its own shares (Special Resolution)   Management   For   For  
12.   To reduce the notice period for general meetings (Special Resolution)   Management   For   For  
13.   To adopt new Articles of Association (Special Resolution)   Management   For   For  

 

 

 

 

ASTRAZENECA PLC

 

Security 046353108 Meeting Type Annual
Ticker Symbol AZN Meeting Date 27-Apr-2023
Record Date 04-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022   Management   For   For  
2.   To confirm dividends   Management   For   For  
3.   To reappoint PricewaterhouseCoopers LLP as Auditor   Management   For   For  
4.   To authorise the Directors to agree the remuneration of the Auditor   Management   For   For  
5a.   Re-election of Director: Michel Demaré   Management   For   For  
5b.   Re-election of Director: Pascal Soriot   Management   For   For  
5c.   Re-election of Director: Aradhana Sarin   Management   For   For  
5d.   Re-election of Director: Philip Broadley   Management   For   For  
5e.   Re-election of Director: Euan Ashley   Management   For   For  
5f.   Re-election of Director: Deborah DiSanzo   Management   For   For  
5g.   Re-election of Director: Diana Layfield   Management   For   For  
5h.   Re-election of Director: Sheri McCoy   Management   For   For  
5i.   Re-election of Director: Tony Mok   Management   For   For  
5j.   Re-election of Director: Nazneen Rahman   Management   For   For  
5k.   Re-election of Director: Andreas Rummelt   Management   For   For  
5l.   Re-election of Director: Marcus Wallenberg   Management   For   For  
6.   To approve the Annual Report on Remuneration for the year ended 31 December 2022   Management   For   For  
7.   To authorise limited political donations   Management   For   For  
8.   To authorise the Directors to allot shares   Management   For   For  
9.   To authorise the Directors to disapply pre-emption rights (Special Resolution)   Management   For   For  
10.   To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution)   Management   For   For  
11.   To authorise the Company to purchase its own shares (Special Resolution)   Management   For   For  
12.   To reduce the notice period for general meetings (Special Resolution)   Management   For   For  
13.   To adopt new Articles of Association (Special Resolution)   Management   For   For  

 

 

 

 

AVANTOR, INC.

 

Security 05352A100 Meeting Type Annual
Ticker Symbol AVTR Meeting Date 11-May-2023
Record Date 17-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Juan Andres   Management   For   For  
1b.   Election of Director: John Carethers   Management   For   For  
1c.   Election of Director: Lan Kang   Management   For   For  
1d.   Election of Director: Joseph Massaro   Management   For   For  
1e.   Election of Director: Mala Murthy   Management   For   For  
1f.   Election of Director: Jonathan Peacock   Management   For   For  
1g.   Election of Director: Michael Severino   Management   For   For  
1h.   Election of Director: Christi Shaw   Management   For   For  
1i.   Election of Director: Michael Stubblefield   Management   For   For  
1j.   Election of Director: Gregory Summe   Management   For   For  
2.   Ratification of the Appointment of Deloitte & Touche LLP as the Company's independent registered accounting firm for 2023.   Management   For   For  
3.   Approve, on an Advisory Basis, Named Executive Officer Compensation.   Management   For   For  

 

BIOGEN INC.

 

Security 09062X103 Meeting Type Annual
Ticker Symbol BIIB Meeting Date 26-Jun-2023
Record Date 20-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable   Management   For   For  
1b.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Caroline D. Dorsa   Management   For   For  
1c.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Maria C. Freire   Management   For   For  
1d.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: William A. Hawkins   Management   For   For  
1e.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable   Management   For   For  
1f.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Jesus B. Mantas   Management   For   For  
1g.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable   Management   For   For  
1h.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Eric K. Rowinsky   Management   For   For  
1i.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Stephen A. Sherwin   Management   For   For  
1j.   Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Christopher A. Viehbacher   Management   For   For  
2.   To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  
3.   Say on Pay - To approve an advisory vote on executive compensation.   Management   For   For  
4.   Say When on Pay - To approve an advisory vote on the frequency of the advisory vote on executive compensation.   Management   1 Year   For  
5.   To elect Susan Langer as a director   Management          

 

 

 

 

BOSTON SCIENTIFIC CORPORATION

 

Security 101137107 Meeting Type Annual
Ticker Symbol BSX Meeting Date 04-May-2023
Record Date 10-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Nelda J. Connors   Management   For   For  
1b.   Election of Director: Charles J. Dockendorff   Management   For   For  
1c.   Election of Director: Yoshiaki Fujimori   Management   For   For  
1d.   Election of Director: Edward J. Ludwig   Management   For   For  
1e.   Election of Director: Michael F. Mahoney   Management   For   For  
1f.   Election of Director: David J. Roux   Management   For   For  
1g.   Election of Director: John E. Sununu   Management   For   For  
1h.   Election of Director: David S. Wichmann   Management   For   For  
1i.   Election of Director: Ellen M. Zane   Management   For   For  
2.   To approve, on a non-binding, advisory basis, the compensation of our named executive officers.   Management   For   For  
3.   To approve, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of our named executive officers.   Management   1 Year   For  
4.   To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2023 fiscal year.   Management   For   For  

 

 

 

 

BRISTOL-MYERS SQUIBB COMPANY

 

Security 110122108 Meeting Type Annual
Ticker Symbol BMY Meeting Date 02-May-2023
Record Date 13-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Election of Director: Peter J. Arduini   Management   For   For  
1B.   Election of Director: Deepak L. Bhatt, M.D., M.P.H.   Management   For   For  
1C.   Election of Director: Giovanni Caforio, M.D.   Management   For   For  
1D.   Election of Director: Julia A. Haller, M.D.   Management   For   For  
1E.   Election of Director: Manuel Hidalgo Medina, M.D., Ph.D.   Management   For   For  
1F.   Election of Director: Paula A. Price   Management   For   For  
1G.   Election of Director: Derica W. Rice   Management   For   For  
1H.   Election of Director: Theodore R. Samuels   Management   For   For  
1I.   Election of Director: Gerald L. Storch   Management   For   For  
1J.   Election of Director: Karen H. Vousden, Ph.D.   Management   For   For  
1K.   Election of Director: Phyllis R. Yale   Management   For   For  
2.   Advisory Vote to Approve the Compensation of our Named Executive Officers.   Management   For   For  
3.   Advisory Vote on the Frequency of the Advisory Vote on the Compensation of our Named Executive Officers.   Management   1 Year   For  
4.   Ratification of the Appointment of an Independent Registered Public Accounting Firm.   Management   For   For  
5.   Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director.   Shareholder   For   Against  
6.   Shareholder Proposal on Workplace Non-Discrimination Audit.   Shareholder   Against   For  
7.   Shareholder Proposal on Special Shareholder Meeting Improvement.   Shareholder   Against   For  

 

CHARLES RIVER LABORATORIES INTL., INC.

 

Security 159864107 Meeting Type Annual
Ticker Symbol CRL Meeting Date 09-May-2023
Record Date 16-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: James C. Foster   Management   For   For  
1b.   Election of Director: Nancy C. Andrews   Management   For   For  
1c.   Election of Director: Robert Bertolini   Management   For   For  
1d.   Election of Director: Deborah T. Kochevar   Management   For   For  
1e.   Election of Director: George Llado, Sr.   Management   For   For  
1f.   Election of Director: Martin W. Mackay   Management   For   For  
1g.   Election of Director: George E. Massaro   Management   For   For  
1h.   Election of Director: C. Richard Reese   Management   For   For  
1i.   Election of Director: Craig B. Thompson   Management   For   For  
1j.   Election of Director: Richard F. Wallman   Management   For   For  
1k.   Election of Director: Virginia M. Wilson   Management   For   For  
2.   Advisory Approval of 2022 Executive Officer Compensation   Management   For   For  
3.   Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation   Management   1 Year   For  
4.   Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2023   Management   For   For  
5.   Proposal to publish a report on non-human primates imported by Charles River Laboratories International, Inc.   Management   Against   For  

 

 

 

 

COMMUNITY HEALTH SYSTEMS, INC.

 

Security 203668108 Meeting Type Annual
Ticker Symbol CYH Meeting Date 09-May-2023
Record Date 13-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Susan W. Brooks   Management   For   For  
1b.   Election of Director: John A. Clerico   Management   For   For  
1c.   Election of Director: Michael Dinkins   Management   For   For  
1d.   Election of Director: James S. Ely III   Management   For   For  
1e.   Election of Director: John A. Fry   Management   For   For  
1f.   Election of Director: Joseph A. Hastings, D.M.D.   Management   For   For  
1g.   Election of Director: Tim L. Hingtgen   Management   For   For  
1h.   Election of Director: Elizabeth T. Hirsch   Management   For   For  
1i.   Election of Director: William Norris Jennings, M.D.   Management   For   For  
1j.   Election of Director: K. Ranga Krishnan, MBBS   Management   For   For  
1k.   Election of Director: Wayne T. Smith   Management   For   For  
1l.   Election of Director: H. James Williams, Ph.D.   Management   For   For  
2.   Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.   Management   For   For  
3.   Proposal to approve on an advisory (non-binding) basis the frequency of future advisory votes on the compensation of the Company's named executive officers.   Management   1 Year   For  
4.   Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors on March 22, 2023, subject to stockholder approval.   Management   For   For  
5.   Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  

 

 

 

 

CVS HEALTH CORPORATION

 

Security 126650100 Meeting Type Annual
Ticker Symbol CVS Meeting Date 18-May-2023
Record Date 20-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Fernando Aguirre   Management   For   For  
1b.   Election of Director: Jeffrey R. Balser, M.D., Ph.D.   Management   For   For  
1c.   Election of Director: C. David Brown II   Management   For   For  
1d.   Election of Director: Alecia A. DeCoudreaux   Management   For   For  
1e.   Election of Director: Nancy-Ann M. DeParle   Management   For   For  
1f.   Election of Director: Roger N. Farah   Management   For   For  
1g.   Election of Director: Anne M. Finucane   Management   For   For  
1h.   Election of Director: Edward J. Ludwig   Management   For   For  
1i.   Election of Director: Karen S. Lynch   Management   For   For  
1j.   Election of Director: Jean-Pierre Millon   Management   For   For  
1k.   Election of Director: Mary L. Schapiro   Management   For   For  
2.   Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2023   Management   For   For  
3.   Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation   Management   For   For  
4.   Proposal to Recommend, on an Advisory Basis, the Frequency of Advisory Votes on Executive Compensation Votes   Management   1 Year   For  
5.   Stockholder Proposal Requesting Paid Sick Leave for All Employees   Shareholder   Against   For  
6.   Stockholder Proposal for Reducing our Ownership Threshold to Request a Special Stockholder Meeting   Shareholder   Against   For  
7.   Stockholder Proposal Regarding "Fair Elections" and Requiring Stockholder Approval of Certain Types of By-law Amendments   Shareholder   Against   For  
8.   Stockholder Proposal Requesting a Report on a "Worker Rights Assessment"   Shareholder   Against   For  
9.   Stockholder Proposal to Prevent Company Directors from Simultaneously Sitting on the Boards of Directors of Any Other Company   Shareholder   Against   For  

 

 

 

 

DANAHER CORPORATION

 

Security 235851102 Meeting Type Annual
Ticker Symbol DHR Meeting Date 09-May-2023
Record Date 10-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Rainer M. Blair   Management   For   For  
1b.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Feroz Dewan   Management   For   For  
1c.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Linda Filler   Management   For   For  
1d.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Teri List   Management   For   For  
1e.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Walter G. Lohr, Jr.   Management   For   For  
1f.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Jessica L. Mega, MD, MPH   Management   For   For  
1g.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Mitchell P. Rales   Management   For   For  
1h.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Steven M. Rales   Management   For   For  
1i.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Pardis C. Sabeti, MD, D. PHIL   Management   For   For  
1j.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: A. Shane Sanders   Management   For   For  
1k.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: John T. Schwieters   Management   For   For  
1l.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Alan G. Spoon   Management   For   For  
1m.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Raymond C. Stevens, Ph.D   Management   For   For  
1n.   Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Elias A. Zerhouni, MD   Management   For   For  
2.   To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2023.   Management   For   For  
3.   To approve on an advisory basis the Company's named executive officer compensation.   Management   For   For  
4.   To hold an advisory vote relating to the frequency of future shareholder advisory votes on the Company's executive officer compensation.   Management   1 Year   For  
5.   To act upon a shareholder proposal requesting adoption of a policy separating the chair and CEO roles and requiring an independent Board Chair whenever possible.   Shareholder   For   Against  
6.   To act upon a shareholder proposal requesting a report to shareholders on the effectiveness of the Company's diversity, equity and inclusion efforts.   Shareholder   Against   For  

 

 

 

 

DEXCOM, INC.

 

Security 252131107 Meeting Type Annual
Ticker Symbol DXCM Meeting Date 18-May-2023
Record Date 29-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director to hold office until our 2024 Annual Meeting: Steven R. Altman   Management   For   For  
1.2   Election of Director to hold office until our 2024 Annual Meeting: Richard A. Collins   Management   For   For  
1.3   Election of Director to hold office until our 2024 Annual Meeting: Karen Dahut   Management   For   For  
1.4   Election of Director to hold office until our 2024 Annual Meeting: Mark G. Foletta   Management   For   For  
1.5   Election of Director to hold office until our 2024 Annual Meeting: Barbara E. Kahn   Management   For   For  
1.6   Election of Director to hold office until our 2024 Annual Meeting: Kyle Malady   Management   For   For  
1.7   Election of Director to hold office until our 2024 Annual Meeting: Eric J. Topol, M.D.   Management   For   For  
2.   To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  
3.   To hold a non-binding vote on an advisory resolution to approve executive compensation.   Management   For   For  
4.   To recommend a non-binding advisory resolution on the frequency of stockholder votes on executive compensation.   Management   1 Year   For  
5.   To hold a non-binding vote on pay equity disclosure.   Management   Against   For  

 

DIVERSIFIED HEALTHCARE TRUST

 

Security 25525P107 Meeting Type Annual
Ticker Symbol DHC Meeting Date 05-Jun-2023
Record Date 17-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Independent Trustee: John L. Harrington   Management   For   For  
1b.   Election of Independent Trustee: Lisa Harris Jones   Management   For   For  
1c.   Election of Independent Trustee: Daniel F. LePage   Management   For   For  
1d.   Election of Independent Trustee: David A. Pierce   Management   For   For  
1e.   Election of Independent Trustee: Jeffrey P. Somers   Management   For   For  
1f.   Election of Managing Trustee: Jennifer F. Francis   Management   For   For  
1g.   Election of Managing Trustee: Adam D. Portnoy   Management   For   For  
2.   Advisory vote to approve executive compensation.   Management   For   For  
3.   Advisory vote on the frequency of future advisory votes to approve executive compensation.   Management   1 Year   For  
4.   Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2023 fiscal year.   Management   For   For  

 

 

 

 

EDWARDS LIFESCIENCES CORPORATION

 

Security 28176E108 Meeting Type Annual
Ticker Symbol EW Meeting Date 11-May-2023
Record Date 13-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Kieran T. Gallahue   Management   For   For  
1.2   Election of Director: Leslie S. Heisz   Management   For   For  
1.3   Election of Director: Paul A. LaViolette   Management   For   For  
1.4   Election of Director: Steven R. Loranger   Management   For   For  
1.5   Election of Director: Martha H. Marsh   Management   For   For  
1.6   Election of Director: Michael A. Mussallem   Management   For   For  
1.7   Election of Director: Ramona Sequeira   Management   For   For  
1.8   Election of Director: Nicholas J. Valeriani   Management   For   For  
1.9   Election of Director: Bernard J. Zovighian   Management   For   For  
2.   Advisory Vote to Approve Named Executive Officer Compensation   Management   For   For  
3.   Advisory Vote to Approve Frequency of Future Advisory Votes on Named Executive Officer Compensation   Management   1 Year   For  
4.   Ratification of Appointment of Independent Registered Public Accounting Firm   Management   For   For  
5.   Approval of Amendment of the Certificate of Incorporation to Provide for Exculpation of Officers   Management   For   For  
6.   Stockholder Proposal regarding Independent Board Chairman Policy   Shareholder   Against   For  

 

ELEVANCE HEALTH, INC.

 

Security 036752103 Meeting Type Annual
Ticker Symbol ELV Meeting Date 10-May-2023
Record Date 17-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Gail K. Boudreaux   Management   For   For  
1b.   Election of Director: R. Kerry Clark   Management   For   For  
1c.   Election of Director: Robert L. Dixon, Jr.   Management   For   For  
1d.   Election of Director: Deanna D. Strable   Management   For   For  
2.   Advisory vote to approve the compensation of our named executive officers.   Management   For   For  
3.   Advisory vote on the frequency of the advisory vote to approve the compensation of our named executive officers.   Management   1 Year   For  
4.   To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2023.   Management   For   For  
5.   Shareholder proposal to allow shareholders owning 10% or more of our common stock to call a special meeting of shareholders.   Shareholder   Against   For  
6.   Shareholder proposal requesting annual reporting from third parties seeking financial support.   Shareholder   Against   For  

 

 

 

 

ELI LILLY AND COMPANY

 

Security 532457108 Meeting Type Annual
Ticker Symbol LLY Meeting Date 01-May-2023
Record Date 21-Feb-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director to serve a three-year term: William G. Kaelin, Jr.   Management   For   For  
1b.   Election of Director to serve a three-year term: David A. Ricks   Management   For   For  
1c.   Election of Director to serve a three-year term: Marschall S. Runge   Management   For   For  
1d.   Election of Director to serve a three-year term: Karen Walker   Management   For   For  
2.   Approval, on an advisory basis, of the compensation paid to the company's named executive officers.   Management   For   For  
3.   Advisory vote on frequency of future advisory votes on named executive officer compensation.   Management   1 Year   For  
4.   Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2023.   Management   For   For  
5.   Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure.   Management   For   For  
6.   Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions.   Management   For   For  
7.   Shareholder proposal to publish an annual report disclosing lobbying activities.   Shareholder   Against   For  
8.   Shareholder proposal to eliminate supermajority voting requirements.   Shareholder   Against   For  
9.   Shareholder proposal to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents.   Shareholder   Against   For  
10.   Shareholder proposal to report on risks of supporting abortion.   Shareholder   Against   For  
11.   Shareholder proposal to disclose lobbying activities and alignment with public policy positions and statements.   Shareholder   Against   For  
12.   Shareholder proposal to report on effectiveness of the company's diversity, equity, and inclusion efforts.   Shareholder   Against   For  
13.   Shareholder proposal to adopt a policy to require certain third-party organizations to annually report expenditures for political activities before Lilly contributes to an organization.   Shareholder   Against   For  

 

 

 

 

FUSION PHARMACEUTICALS INC

 

Security 36118A100 Meeting Type Annual
Ticker Symbol FUSN Meeting Date 14-Jun-2023
Record Date 18-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director to serve until the next annual meeting: Donald Bergstrom, M.D., Ph.D.   Management   For   For  
1.2   Election of Director to serve until the next annual meeting: Pablo Cagnoni, M.D.   Management   For   For  
1.3   Election of Director to serve until the next annual meeting: Johan Christenson, M.D., Ph.D.   Management   For   For  
1.4   Election of Director to serve until the next annual meeting: Barbara Duncan   Management   For   For  
1.5   Election of Director to serve until the next annual meeting: Steve Gannon   Management   For   For  
1.6   Election of Director to serve until the next annual meeting: Chau Khuong   Management   For   For  
1.7   Election of Director to serve until the next annual meeting: Philina Lee, Ph.D.   Management   For   For  
1.8   Election of Director to serve until the next annual meeting: Heather Preston, M.D.   Management   For   For  
1.9   Election of Director to serve until the next annual meeting: John Valliant, Ph.D.   Management   For   For  
2.   To appoint PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  

 

GALERA THERAPEUTICS, INC.

 

Security 36338D108 Meeting Type Annual
Ticker Symbol GRTX Meeting Date 14-Jun-2023
Record Date 21-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1 Michael Powell, Ph.D.       For   For  
    2 Linda West       For   For  
2.   To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  

 

 

 

 

GILEAD SCIENCES, INC.

 

Security 375558103 Meeting Type Annual
Ticker Symbol GILD Meeting Date 03-May-2023
Record Date 15-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Jacqueline K. Barton, Ph.D.   Management   For   For  
1b.   Election of Director: Jeffrey A. Bluestone, Ph.D.   Management   For   For  
1c.   Election of Director: Sandra J. Horning, M.D.   Management   For   For  
1d.   Election of Director: Kelly A. Kramer   Management   For   For  
1e.   Election of Director: Kevin E. Lofton   Management   For   For  
1f.   Election of Director: Harish Manwani   Management   For   For  
1g.   Election of Director: Daniel P. O'Day   Management   For   For  
1h.   Election of Director: Javier J. Rodriguez   Management   For   For  
1i.   Election of Director: Anthony Welters   Management   For   For  
2.   To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  
3.   To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.   Management   For   For  
4.   To approve, on an advisory basis, the frequency of future advisory stockholder votes on executive compensation.   Management   1 Year   For  
5.   To approve an amendment and restatement of the Gilead Sciences, Inc. Employee Stock Purchase Plan and the Gilead Sciences, Inc. International Employee Stock Purchase Plan.   Management   For   For  
6.   To vote on a stockholder proposal, if properly presented at the meeting, requesting the Board implement a process to nominate at least one more candidate than the number of directors to be elected.   Shareholder   Against   For  
7.   To vote on a stockholder proposal, if properly presented at the meeting, requesting the Board amend the company governing documents to give street name shares and non-street name shares an equal right to call a special stockholder meeting.   Shareholder   Against   For  
8.   To vote on a stockholder proposal, if properly presented at the meeting, requesting a report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents.   Shareholder   Against   For  

 

 

 

 

GLOBAL MEDICAL REIT INC.

 

Security 37954A204 Meeting Type Annual
Ticker Symbol GMRE Meeting Date 10-May-2023
Record Date 15-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director to serve until next annual meeting: Jeffrey M. Busch   Management   For   For  
1.2   Election of Director to serve until next annual meeting: Matthew Cypher   Management   For   For  
1.3   Election of Director to serve until next annual meeting: Ronald Marston   Management   For   For  
1.4   Election of Director to serve until next annual meeting: Henry E. Cole   Management   For   For  
1.5   Election of Director to serve until next annual meeting: Zhang Huiqi   Management   For   For  
1.6   Election of Director to serve until next annual meeting: Paula R. Crowley   Management   For   For  
1.7   Election of Director to serve until next annual meeting: Lori Wittman   Management   For   For  
2.   Advisory vote to approve the compensation of the Company's named executive officers as described in the accompanying Proxy Statement.   Management   For   For  
3.   To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023.   Management   For   For  

 

GUARDANT HEALTH, INC.

 

Security 40131M109 Meeting Type Annual
Ticker Symbol GH Meeting Date 14-Jun-2023
Record Date 17-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Class II Director: Ian Clark   Management   For   For  
1b.   Election of Class II Director: Meghan Joyce   Management   For   For  
1c.   Election of Class II Director: Samir Kaul   Management   For   For  
2.   Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2023.   Management   For   For  
3.   Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.   Management   For   For  

 

 

 

 

HCA HEALTHCARE, INC.

 

Security 40412C101 Meeting Type Annual
Ticker Symbol HCA Meeting Date 19-Apr-2023
Record Date 24-Feb-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Thomas F. Frist III   Management   For   For  
1b.   Election of Director: Samuel N. Hazen   Management   For   For  
1c.   Election of Director: Meg G. Crofton   Management   For   For  
1d.   Election of Director: Robert J. Dennis   Management   For   For  
1e.   Election of Director: Nancy-Ann DeParle   Management   For   For  
1f.   Election of Director: William R. Frist   Management   For   For  
1g.   Election of Director: Hugh F. Johnston   Management   For   For  
1h.   Election of Director: Michael W. Michelson   Management   For   For  
1i.   Election of Director: Wayne J. Riley, M.D.   Management   For   For  
1j.   Election of Director: Andrea B. Smith   Management   For   For  
2.   To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2023.   Management   For   For  
3.   To approve the HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan.   Management   For   For  
4.   Advisory vote to approve named executive officer compensation.   Management   For   For  
5.   Stockholder proposal, if properly presented at the meeting, regarding political spending disclosure.   Shareholder   Against   For  
6.   Stockholder proposal, if properly presented at the meeting, regarding amendment to Patient Safety and Quality of Care Committee charter.   Shareholder   Against   For  

 

HEALTHCARE REALTY TRUST INCORPORATED

 

Security 42226K105 Meeting Type Annual
Ticker Symbol HR Meeting Date 05-Jun-2023
Record Date 14-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Todd J. Meredith   Management   For   For  
1b.   Election of Director: John V. Abbott   Management   For   For  
1c.   Election of Director: Nancy H. Agee   Management   For   For  
1d.   Election of Director: W. Bradley Blair II   Management   For   For  
1e.   Election of Director: Vicki U. Booth   Management   For   For  
1f.   Election of Director: Edward H. Braman   Management   For   For  
1g.   Election of Director: Ajay Gupta   Management   For   For  
1h.   Election of Director: James J. Kilroy   Management   For   For  
1i.   Election of Director: Jay P. Leupp   Management   For   For  
1j.   Election of Director: Peter F. Lyle   Management   For   For  
1k.   Election of Director: Constance B. Moore   Management   For   For  
1l.   Election of Director: John Knox Singleton   Management   For   For  
1m.   Election of Director: Christann M. Vasquez   Management   For   For  
2.   To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2023 fiscal year.   Management   For   For  
3.   To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the stockholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2023 Annual Meeting of Stockholders.   Management   For   For  
4.   To approve, on a non-binding advisory basis, the frequency of a non-binding advisory vote on executive compensation.   Management   1 Year   For  

 

 

 

 

HEALTHCARE TRUST OF AMERICA, INC.

 

Security 42225P501 Meeting Type Special
Ticker Symbol HTA Meeting Date 15-Jul-2022
Record Date 10-Jun-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Company Issuance Proposal. To approve the issuance of shares of class A common stock, $0.01 par value per share ("Company Common Stock"), of Healthcare Trust of America, Inc. (the "Company"), pursuant to the Agreement and Plan of Merger, dated as of February 28, 2022, by and among the Company, Healthcare Trust of America Holdings, LP, Healthcare Realty Trust Incorporated, and HR Acquisition 2, LLC (the "Merger").   Management   For   For  
2.   Company Golden Parachute Proposal. To approve, in a non-binding advisory vote, the "golden parachute" compensation that may become vested and payable to the Company's named executive officers in connection with the Merger.   Management   For   For  
3.   Company Adjournment Proposal. To approve one or more adjournments of the Company Special Meeting to another date, time, place, or format, if necessary or appropriate, including to solicit additional proxies in favor of the proposal to approve the issuance of shares of Company Common Stock in connection with the Merger.   Management   For   For  

 

HEALTHPEAK PROPERTIES, INC

 

Security 42250P103 Meeting Type Annual
Ticker Symbol PEAK Meeting Date 27-Apr-2023
Record Date 01-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Scott M. Brinker   Management   For   For  
1b.   Election of Director: Brian G. Cartwright   Management   For   For  
1c.   Election of Director: James B. Connor   Management   For   For  
1d.   Election of Director: Christine N. Garvey   Management   For   For  
1e.   Election of Director: R. Kent Griffin, Jr.   Management   For   For  
1f.   Election of Director: David B. Henry   Management   For   For  
1g.   Election of Director: Sara G. Lewis   Management   For   For  
1h.   Election of Director: Katherine M. Sandstrom   Management   For   For  
2.   Approval of 2022 executive compensation on an advisory basis.   Management   For   For  
3.   Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation.   Management   1 Year   For  
4.   Approval of the Healthpeak Properties, Inc. 2023 Performance Incentive Plan.   Management   For   For  
5.   Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2023.   Management   For   For  

 

 

 

 

HORIZON THERAPEUTICS PLC

 

Security G46188101 Meeting Type Special
Ticker Symbol HZNP Meeting Date 24-Feb-2023
Record Date 19-Jan-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Ordinary Resolution to approve the Scheme of Arrangement and authorize the directors of Horizon to take all such actions as they consider necessary or appropriate for carrying the Scheme of Arrangement into effect.   Management   For   For  
2.   Special Resolution to amend the articles of association of Horizon so that any Horizon Shares that are issued on or after the Voting Record Time to persons other than Acquirer Sub or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or be immediately and automatically acquired by Acquirer Sub and/or its nominee(s) for the Scheme Consideration.   Management   For   For  
3.   Ordinary Resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Horizon and its named executive officers relating to the Transaction.   Management   For   For  
4.   Ordinary Resolution to approve any motion by the Chairman to adjourn the EGM or any adjournments thereof, to solicit additional proxies in favor of the approval of the resolutions if there are insufficient votes at the time of the EGM to approve resolutions 1 and 2.   Management   For   For  

 

 

 

 

HORIZON THERAPEUTICS PLC

 

Security G46188111 Meeting Type Special
Ticker Symbol HZNP Meeting Date 24-Feb-2023
Record Date 19-Jan-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   That the Scheme of Arrangement in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be agreed to.   Management   For   For  

 

HUMANA INC.

 

Security 444859102 Meeting Type Annual
Ticker Symbol HUM Meeting Date 20-Apr-2023
Record Date 28-Feb-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a)   Election of Director: Raquel C. Bono, M.D.   Management   For   For  
1b)   Election of Director: Bruce D. Broussard   Management   For   For  
1c)   Election of Director: Frank A. D'Amelio   Management   For   For  
1d)   Election of Director: David T. Feinberg, M.D.   Management   For   For  
1e)   Election of Director: Wayne A. I. Frederick, M.D.   Management   For   For  
1f)   Election of Director: John W. Garratt   Management   For   For  
1g)   Election of Director: Kurt J. Hilzinger   Management   For   For  
1h)   Election of Director: Karen W. Katz   Management   For   For  
1i)   Election of Director: Marcy S. Klevorn   Management   For   For  
1j)   Election of Director: William J. McDonald   Management   For   For  
1k)   Election of Director: Jorge S. Mesquita   Management   For   For  
1l)   Election of Director: Brad D. Smith   Management   For   For  
2.   The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.   Management   For   For  
3.   Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2023 proxy statement.   Management   For   For  
4.   Non-binding advisory vote for the approval of the frequency with which future stockholder votes on the compensation of the named executive officers will be held.   Management   1 Year   For  

 

 

 

 

ICON PLC

 

Security G4705A100 Meeting Type Annual
Ticker Symbol ICLR Meeting Date 26-Jul-2022
Record Date 06-Jun-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Dr. Steve Cutler   Management   For   For  
1.2   Election of Director: Dr. John Climax   Management   For   For  
1.3   Election of Director: Mr. Ronan Murphy   Management   For   For  
2.   To review the Company's affairs and consider the Accounts and Reports   Management   For   For  
3.   To authorise the fixing of the Auditors' Remuneration   Management   For   For  
4.   To authorise the Company to allot shares   Management   For   For  
5.   To disapply the statutory pre-emption rights   Management   For   For  
6.   To disapply the statutory pre-emption rights for funding capital investment or acquisitions   Management   For   For  
7.   To authorise the Company to make market purchases of shares   Management   For   For  
8.   To authorise the price range at which the Company can reissue shares that it holds as treasury shares   Management   For   For  

 

IDEXX LABORATORIES, INC.

 

Security 45168D104 Meeting Type Annual
Ticker Symbol IDXX Meeting Date 17-May-2023
Record Date 20-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director (Proposal One): Daniel M. Junius   Management   For   For  
1b.   Election of Director (Proposal One): Lawrence D. Kingsley   Management   For   For  
1c.   Election of Director (Proposal One): Sophie V. Vandebroek, PhD   Management   For   For  
2.   Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two).   Management   For   For  
3.   Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).   Management   For   For  
4.   Advisory Vote on the Frequency of Advisory Votes on Executive Compensation. To recommend, by nonbinding advisory vote, the frequency of future advisory votes on the Company's executive compensation (Proposal Four).   Management   1 Year   For  

 

 

 

 

ILLUMINA, INC.

 

Security 452327109 Meeting Type Contested-Annual
Ticker Symbol ILMN Meeting Date 25-May-2023
Record Date 03-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1A.   Illumina Nominee: Frances Arnold, Ph.D.   Management   For   For  
1B.   Illumina Nominee: Francis A. deSouza   Management   Withheld   For  
1C.   Illumina Nominee: Caroline D. Dorsa   Management   Withheld   For  
1D.   Illumina Nominee: Robert S. Epstein, M.D.   Management   Withheld   For  
1E.   Illumina Nominee: Scott Gottlieb, M.D.   Management   For   For  
1F.   Illumina Nominee: Gary S. Guthart, Ph.D.   Management   Withheld   For  
1G.   Illumina Nominee: Philip W. Schiller   Management   For   For  
1H.   Illumina Nominee: Susan E. Siegel   Management   For   For  
1I.   Illumina Nominee: John W. Thompson   Management   Withheld   For  
1J.   Icahn Group Nominee OPPOSED by the Company: Vincent J. Intrieri   Management   For   For  
1K.   Icahn Group Nominee OPPOSED by the Company: Jesse A. Lynn   Management   Withheld   For  
1L.   Icahn Group Nominee OPPOSED by the Company: Andrew J. Teno   Management   Withheld   For  
2.   To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  
3.   To approve, on an advisory basis, the compensation provided to our named executive officers as disclosed in the Proxy Statement.   Management   Against   Against  
4.   To approve, on an advisory basis, the frequency of holding an advisory vote to approve compensation provided to our "named executive officers".   Management   1 Year   For  
5.   To approve certain amendments to the Illumina, Inc. 2015 Stock and Incentive Plan   Management   For   For  

 

INTUITIVE SURGICAL, INC.

 

Security 46120E602 Meeting Type Annual
Ticker Symbol ISRG Meeting Date 27-Apr-2023
Record Date 28-Feb-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Craig H. Barratt, Ph.D.   Management   For   For  
1b.   Election of Director: Joseph C. Beery   Management   For   For  
1c.   Election of Director: Gary S. Guthart, Ph.D.   Management   For   For  
1d.   Election of Director: Amal M. Johnson   Management   For   For  
1e.   Election of Director: Don R. Kania, Ph.D.   Management   For   For  
1f.   Election of Director: Amy L. Ladd, M.D.   Management   For   For  
1g.   Election of Director: Keith R. Leonard, Jr.   Management   For   For  
1h.   Election of Director: Alan J. Levy, Ph.D.   Management   For   For  
1i.   Election of Director: Jami Dover Nachtsheim   Management   For   For  
1j.   Election of Director: Monica P. Reed, M.D.   Management   For   For  
1k.   Election of Director: Mark J. Rubash   Management   For   For  
2.   To approve, by advisory vote, the compensation of the Company's Named Executive Officers   Management   For   For  
3.   To approve, by advisory vote, the frequency of the advisory vote on the compensation of the Company's Named Executive Officers.   Management   1 Year   For  
4.   The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  
5.   The stockholder proposal regarding pay equity disclosure.   Shareholder   Against   For  

 

 

 

 

IO LIGHT HOLDINGS, INC

 

Security N/A Meeting Type Written Consent
Ticker Symbol N/A Meeting Date 27-Sep-2022
Record Date N/A    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Approval of Subsidiary Transfer Documents   Management   For   For  
2.   General Resolutions   Management   For   For  

 

IO LIGHT HOLDINGS, INC

 

Security N/A Meeting Type Written Consent
Ticker Symbol N/A Meeting Date 30-Dec-2022
Record Date N/A    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   Approval of Series B Financing   Management   For   For  
2.   Approval of Amended and Restated Certification of Incorporation   Management   For   For  
3.   Approval of Amended and Restated Stockholders Agreement   Management   For   For  

 

 

 

 

IQVIA HOLDINGS INC.

 

Security 46266C105 Meeting Type Annual
Ticker Symbol IQV Meeting Date 18-Apr-2023
Record Date 17-Feb-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Carol J. Burt   Management   For   For  
1b.   Election of Director: Colleen A. Goggins   Management   For   For  
1c.   Election of Director: Sheila A. Stamps   Management   For   For  
2.   Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).   Management   For   For  
3.   Approve a Company proposal to amend IQVIA's Certificate of Incorporation to adopt a stockholders' right to request a special stockholders' meeting.   Management   For   For  
4.   If properly presented, a stockholder proposal concerning special stockholder meetings.   Shareholder   For   Against  
5.   If properly presented, a stockholder proposal for separate Chairman and Chief Executive Officer roles.   Shareholder   For   Against  
6.   Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2023.   Management   For   For  

 

JAZZ PHARMACEUTICALS PLC

 

Security G50871105 Meeting Type Annual
Ticker Symbol JAZZ Meeting Date 28-Jul-2022
Record Date 01-Jun-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director to hold office until the 2025 Annual General Meeting: Jennifer E. Cook   Management   For   For  
1b.   Election of Director to hold office until the 2025 Annual General Meeting: Patrick G. Enright   Management   For   For  
1c.   Election of Director to hold office until the 2025 Annual General Meeting: Seamus Mulligan   Management   For   For  
1d.   Election of Director to hold office until the 2025 Annual General Meeting: Norbert G. Riedel, Ph.D.   Management   For   For  
2.   To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals plc for the fiscal year ending December 31, 2022 and to authorize, in a binding vote, the Board of Directors, acting through the audit committee, to determine KPMG's remuneration.   Management   For   For  
3.   To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement.   Management   For   For  
4.   To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply.   Management   For   For  
5.   To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the Annual General Meeting to approve Proposal 4.   Management   For   For  

 

 

 

 

JOHNSON & JOHNSON

 

Security 478160104 Meeting Type Annual
Ticker Symbol JNJ Meeting Date 27-Apr-2023
Record Date 28-Feb-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Darius Adamczyk   Management   For   For  
1b.   Election of Director: Mary C. Beckerle   Management   For   For  
1c.   Election of Director: D. Scott Davis   Management   For   For  
1d.   Election of Director: Jennifer A. Doudna   Management   For   For  
1e.   Election of Director: Joaquin Duato   Management   For   For  
1f.   Election of Director: Marillyn A. Hewson   Management   For   For  
1g.   Election of Director: Paula A. Johnson   Management   For   For  
1h.   Election of Director: Hubert Joly   Management   For   For  
1I.   Election of Director: Mark B. McClellan   Management   For   For  
1j.   Election of Director: Anne M. Mulcahy   Management   For   For  
1k.   Election of Director: Mark A. Weinberger   Management   For   For  
1l.   Election of Director: Nadja Y. West   Management   For   For  
2.   Advisory Vote to Approve Named Executive Officer Compensation   Management   For   For  
3.   Advisory Vote on the Frequency of Voting to Approve Named Executive Officer Compensation   Management   1 Year   For  
4.   Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm   Management   For   For  
5.   Proposal Withdrawn (Federal Securities Laws Mandatory Arbitration Bylaw)   Shareholder   Abstain    
6.   Vaccine Pricing Report   Shareholder   Against   For  
7.   Executive Compensation Adjustment Policy   Shareholder   Against   For  
8.   Impact of Extended Patent Exclusivities on Product Access   Shareholder   Against   For  

 

 

 

 

LABORATORY CORP. OF AMERICA HOLDINGS

 

Security 50540R409 Meeting Type Annual
Ticker Symbol LH Meeting Date 11-May-2023
Record Date 16-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Kerrii B. Anderson   Management   For   For  
1b.   Election of Director: Jean-Luc Bélingard   Management   For   For  
1c.   Election of Director: Jeffrey A. Davis   Management   For   For  
1d.   Election of Director: D. Gary Gilliland, M.D., Ph.D.   Management   For   For  
1e.   Election of Director: Kirsten M. Kliphouse   Management   For   For  
1f.   Election of Director: Garheng Kong, M.D., Ph.D.   Management   For   For  
1g.   Election of Director: Peter M. Neupert   Management   For   For  
1h.   Election of Director: Richelle P. Parham   Management   For   For  
1i.   Election of Director: Adam H. Schechter   Management   For   For  
1j.   Election of Director: Kathryn E. Wengel   Management   For   For  
1k.   Election of Director: R. Sanders Williams, M.D.   Management   For   For  
2.   To approve, by non-binding vote, executive compensation.   Management   For   For  
3.   To recommend by non-binding vote, the frequency of future non-binding votes on executive compensation.   Management   1 Year   For  
4.   Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2023.   Management   For   For  
5.   Shareholder proposal relating to a policy regarding separation of the roles of Board Chairman and Chief Executive Officer.   Shareholder   For   Against  
6.   Shareholder proposal regarding a Board report on transport of nonhuman primates within the U.S.   Shareholder   Against   For  
7.   Shareholder proposal regarding a Board report on known risks of fulfilling information requests and mitigation strategies.   Shareholder   Against   For  

 

LANTHEUS HOLDINGS, INC.

 

Security 516544103 Meeting Type Annual
Ticker Symbol LNTH Meeting Date 27-Apr-2023
Record Date 06-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Class II Director: Ms. Minnie Baylor-Henry   Management   For   For  
1.2   Election of Class II Director: Mr. Heinz Mäusli   Management   For   For  
1.3   Election of Class II Director: Ms. Julie McHugh   Management   For   For  
2.   The approval, on an advisory basis, of the compensation paid to our named executive officers.   Management   For   For  
3.   The approval of the Lantheus Holdings, Inc. 2023 Employee Stock Purchase Plan.   Management   For   For  
4.   The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  

 

 

 

 

LIVANOVA PLC

 

Security G5509L101 Meeting Type Annual
Ticker Symbol LIVN Meeting Date 12-Jun-2023
Record Date 21-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Francesco Bianchi   Management   For   For  
1b.   Election of Director: Stacy Enxing Seng   Management   For   For  
1c.   Election of Director: William Kozy   Management   For   For  
1d.   Election of Director: Daniel Moore   Management   For   For  
1e.   Election of Director: Dr. Sharon O'Kane   Management   For   For  
1f.   Election of Director: Andrea Saia   Management   For   For  
1g.   Election of Director: Todd Schermerhorn   Management   For   For  
1h.   Election of Director: Brooke Story   Management   For   For  
1i.   Election of Director: Peter Wilver   Management   For   For  
2.   Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("US Say-on-Pay").   Management   For   For  
3.   Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2023.   Management   For   For  
4.   Ordinary Resolution: To approve the Amended and Restated LivaNova PLC 2022 Incentive Award Plan.   Management   For   For  
5.   Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act") to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of £10,770,848, provided that: (A) (unless previously revoked, varied or renewed by the Company) this authority will expire at the end ...(due to space limits, see proxy material for full proposal).   Management   For   For  
6.   Special Resolution: Subject to the passing of resolution 5 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 5, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' ...(due to space limits, see proxy material for full proposal).   Management   For   For  
7.   Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the period ended December 31, 2022.   Management   For   For  
8.   Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2022, together with the reports of the directors and auditors thereon.   Management   For   For  
9.   Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2023.   Management   For   For  
10.   Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor.   Management   For   For  

 

 

 

 

LTC PROPERTIES, INC.

 

Security 502175102 Meeting Type Annual
Ticker Symbol LTC Meeting Date 24-May-2023
Record Date 10-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Cornelia Cheng   Management   For   For  
1b.   Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Boyd W. Hendrickson   Management   For   For  
1c.   Election of Director to hold office until the 2024 Annual Meeting of Stockholders: James J. Pieczynski   Management   For   For  
1d.   Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Devra G. Shapiro   Management   For   For  
1e.   Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Wendy L. Simpson   Management   For   For  
1f.   Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Timothy J. Triche   Management   For   For  
2.   Ratification of independent registered public accounting firm.   Management   For   For  
3.   Advisory vote to approve named executive officer compensation.   Management   For   For  
4.   Advisory vote on the frequency of the advisory vote on executive compensation.   Management   1 Year   For  

 

 

 

 

MCKESSON CORPORATION

 

Security 58155Q103 Meeting Type Annual
Ticker Symbol MCK Meeting Date 22-Jul-2022
Record Date 27-May-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director for a one-year term: Richard H. Carmona, M.D.   Management   For   For  
1b.   Election of Director for a one-year term: Dominic J. Caruso   Management   For   For  
1c.   Election of Director for a one-year term: W. Roy Dunbar   Management   For   For  
1d.   Election of Director for a one-year term: James H. Hinton   Management   For   For  
1e.   Election of Director for a one-year term: Donald R. Knauss   Management   For   For  
1f.   Election of Director for a one-year term: Bradley E. Lerman   Management   For   For  
1g.   Election of Director for a one-year term: Linda P. Mantia   Management   For   For  
1h.   Election of Director for a one-year term: Maria Martinez   Management   For   For  
1i.   Election of Director for a one-year term: Susan R. Salka   Management   For   For  
1j.   Election of Director for a one-year term: Brian S. Tyler   Management   For   For  
1k.   Election of Director for a one-year term: Kathleen Wilson-Thompson   Management   For   For  
2.   Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2023.   Management   For   For  
3.   Advisory vote on executive compensation.   Management   For   For  
4.   Approval of our 2022 Stock Plan.   Management   For   For  
5.   Approval of Amendment to our 2000 Employee Stock Purchase Plan.   Management   For   For  
6.   Shareholder Proposal on Special Shareholder Meeting Improvement.   Shareholder   Against   For  
7.   Shareholder Proposal on Transparency in Rule 10b5-1 Trading Policy.   Shareholder   Against   For  

 

 

 

 

MEDICAL PROPERTIES TRUST, INC.

 

Security 58463J304 Meeting Type Annual
Ticker Symbol MPW Meeting Date 25-May-2023
Record Date 29-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.1   Election of Director: Edward K. Aldag, Jr.   Management   For   For  
1.2   Election of Director: G. Steven Dawson   Management   For   For  
1.3   Election of Director: R. Steven Hamner   Management   For   For  
1.4   Election of Director: Caterina A. Mozingo   Management   For   For  
1.5   Election of Director: Emily W. Murphy   Management   For   For  
1.6   Election of Director: Elizabeth N. Pitman   Management   For   For  
1.7   Election of Director: D. Paul Sparks, Jr.   Management   For   For  
1.8   Election of Director: Michael G. Stewart   Management   For   For  
1.9   Election of Director: C. Reynolds Thompson, III   Management   For   For  
2.   To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023.   Management   For   For  
3.   To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.   Management   For   For  
4.   To recommend, on a non-binding, advisory basis, the frequency of future advisory votes on executive compensation.   Management   1 Year   For  

 

MEDTRONIC PLC

 

Security G5960L103 Meeting Type Annual
Ticker Symbol MDT Meeting Date 08-Dec-2022
Record Date 11-Oct-2022    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director to hold office until the 2023 Annual General Meeting: Richard H. Anderson   Management   For   For  
1b.   Election of Director to hold office until the 2023 Annual General Meeting: Craig Arnold   Management   For   For  
1c.   Election of Director to hold office until the 2023 Annual General Meeting: Scott C. Donnelly   Management   For   For  
1d.   Election of Director to hold office until the 2023 Annual General Meeting: Lidia L. Fonseca   Management   For   For  
1e.   Election of Director to hold office until the 2023 Annual General Meeting: Andrea J. Goldsmith, Ph.D.   Management   For   For  
1f.   Election of Director to hold office until the 2023 Annual General Meeting: Randall J. Hogan, III   Management   For   For  
1g.   Election of Director to hold office until the 2023 Annual General Meeting: Kevin E. Lofton   Management   For   For  
1h.   Election of Director to hold office until the 2023 Annual General Meeting: Geoffrey S. Martha   Management   For   For  
1i.   Election of Director to hold office until the 2023 Annual General Meeting: Elizabeth G. Nabel, M.D.   Management   For   For  
1j.   Election of Director to hold office until the 2023 Annual General Meeting: Denise M. O'Leary   Management   For   For  
1k.   Election of Director to hold office until the 2023 Annual General Meeting: Kendall J. Powell   Management   For   For  
2.   Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2023 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.   Management   For   For  
3.   Approving, on an advisory basis, the Company's executive compensation.   Management   For   For  
4.   Renewing the Board of Directors' authority to issue shares under Irish law.   Management   For   For  
5.   Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law.   Management   For   For  
6.   Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.   Management   For   For  

 

 

 

 

MERCK & CO., INC.

 

Security 58933Y105 Meeting Type Annual
Ticker Symbol MRK Meeting Date 23-May-2023
Record Date 24-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Douglas M. Baker, Jr.   Management   For   For  
1b.   Election of Director: Mary Ellen Coe   Management   For   For  
1c.   Election of Director: Pamela J. Craig   Management   For   For  
1d.   Election of Director: Robert M. Davis   Management   For   For  
1e.   Election of Director: Thomas H. Glocer   Management   For   For  
1f.   Election of Director: Risa J. Lavizzo-Mourey, M.D.   Management   For   For  
1g.   Election of Director: Stephen L. Mayo, Ph.D.   Management   For   For  
1h.   Election of Director: Paul B. Rothman, M.D.   Management   For   For  
1i.   Election of Director: Patricia F. Russo   Management   For   For  
1j.   Election of Director: Christine E. Seidman, M.D.   Management   For   For  
1k.   Election of Director: Inge G. Thulin   Management   For   For  
1l.   Election of Director: Kathy J. Warden   Management   For   For  
1m.   Election of Director: Peter C. Wendell   Management   For   For  
2.   Non-binding advisory vote to approve the compensation of our named executive officers.   Management   For   For  
3.   Non-binding advisory vote to approve the frequency of future votes to approve the compensation of our named executive officers.   Management   1 Year   For  
4.   Ratification of the appointment of the Company's independent registered public accounting firm for 2023.   Management   For   For  
5.   Shareholder proposal regarding business operations in China.   Shareholder   Against   For  
6.   Shareholder proposal regarding access to COVID-19 products.   Shareholder   Against   For  
7.   Shareholder proposal regarding indirect political spending.   Shareholder   Against   For  
8.   Shareholder proposal regarding patents and access.   Shareholder   Against   For  
9.   Shareholder proposal regarding a congruency report of partnerships with globalist organizations.   Shareholder   Against   For  
10.   Shareholder proposal regarding an independent board chairman.   Shareholder   For   Against  

 

 

 

 

MODERNA, INC.

 

Security 60770K107 Meeting Type Annual
Ticker Symbol MRNA Meeting Date 03-May-2023
Record Date 08-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1.   DIRECTOR   Management          
    1 Stephen Berenson       For   For  
    2 Sandra Horning, M.D.       For   For  
    3 Paul Sagan       For   For  
2.   To approve, on a non-binding, advisory basis, the compensation of our named executive officers.   Management   For   For  
3.   To ratify the appointment of Ernst & Young LLP as our registered independent public accounting firm for the year ending December 31, 2023.   Management   For   For  
4.   To vote on a shareholder proposal requesting a report on transferring intellectual property.   Shareholder   Against   For  

 

MOLINA HEALTHCARE, INC.

 

Security 60855R100 Meeting Type Annual
Ticker Symbol MOH Meeting Date 03-May-2023
Record Date 08-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director to hold office until the 2024 Annual Meeting: Barbara L. Brasier   Management   For   For  
1b.   Election of Director to hold office until the 2024 Annual Meeting: Daniel Cooperman   Management   For   For  
1c.   Election of Director to hold office until the 2024 Annual Meeting: Stephen H. Lockhart   Management   For   For  
1d.   Election of Director to hold office until the 2024 Annual Meeting: Steven J. Orlando   Management   For   For  
1e.   Election of Director to hold office until the 2024 Annual Meeting: Ronna E. Romney   Management   For   For  
1f.   Election of Director to hold office until the 2024 Annual Meeting: Richard M. Schapiro   Management   For   For  
1g.   Election of Director to hold office until the 2024 Annual Meeting: Dale B. Wolf   Management   For   For  
1h.   Election of Director to hold office until the 2024 Annual Meeting: Richard C. Zoretic   Management   For   For  
1i.   Election of Director to hold office until the 2024 Annual Meeting: Joseph M. Zubretsky   Management   For   For  
2.   To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.   Management   For   For  
3.   To conduct an advisory vote on the frequency of a stockholder vote on the compensation of our named executive officers.   Management   1 Year   For  
4.   To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2023.   Management   For   For  

 

 

 

 

NATIONAL HEALTH INVESTORS, INC.

 

Security 63633D104 Meeting Type Annual
Ticker Symbol NHI Meeting Date 05-May-2023
Record Date 10-Mar-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: W. Andrew Adams   Management   For   For  
1b.   Election of Director: Tracy M.J. Colden   Management   For   For  
1c.   Election of Director: Robert A. McCabe, Jr.   Management   For   For  
2.   Approve the Amended and Restated 2019 Stock Incentive Plan.   Management   For   For  
3.   Approve the advisory resolution approving the compensation of the named executive officers as disclosed in the accompanying Proxy Statement.   Management   For   For  
4.   Approve the advisory vote on the frequency of the advisory vote on the compensation of the named executive officers.   Management   1 Year   For  
5.   Ratify the audit committee's selection of BDO USA, LLP as independent registered public accounting firm for the year ending December 31, 2023.   Management   For   For  

 

OCULIS HOLDING AG

 

Security N/A Meeting Type Written Consent
Ticker Symbol N/A Meeting Date 8-Jul-2022
Record Date N/A    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1   Change of Designation of the Existing Series C Preferred Shares and Revision of the Articles of Association   Management   For   For  
2.   Ordinary Share Capital Increase   Management   For   For  
3.   Conditional Share Capital Increase   Management   For   For  
4.   Election of Member to the Board of Directors   Management   For   For  

 

 

 

 

OMEGA HEALTHCARE INVESTORS, INC.

 

Security 681936100 Meeting Type Annual
Ticker Symbol OHI Meeting Date 05-Jun-2023
Record Date 06-Apr-2023    

 

Item   Proposal   Proposed
by
  Vote   For/Against
Management
 
1a.   Election of Director: Kapila K. Anand   Management   For   For  
1b.   Election of Director: Craig R. Callen   Management   For   For  
1c.   Election of Director: Dr. Lisa C. Egbuonu-Davis   Management   For   For  
1d.   Election of Director: Barbara B. Hill   Management   For   For  
1e.   Election of Director: Kevin J. Jacobs   Management   For   For  
1f.   Election of Director: C. Taylor Pickett   Management   For   For  
1g.   Election of Director: Stephen D. Plavin   Management   For   For  
1h.   Election of Director: Burke W. Whitman   Management   For   For  
2.   Ratification of Independent Auditors Ernst & Young LLP for fiscal year 2023.   Management   For   For  
3.   Approval, on an Advisory Basis, of Executive Compensation.   Management   For   For  
4.   Advisory Vote on Frequency of Advisory Votes on Executive Compensation.   Management   1 Year